The protocol has been published at clinicaltrials.
Post# of 148831
Quote:
The protocol has been published at clinicaltrials.gov. I noticed that they did not exclude patients with the Delta 32 mutation (single or double allele). I wonder if this is a mistake -- ? Would be happy to if anyone with a better understanding of Leron's MOA eased my mind.
One of the inclusion criteria is expression of CCR5 on the tumor so patients with double allele deletion would be excluded but not single allele.